ClinicalTrials.Veeva

Menu

Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma

M

Marwa Mahmoud Hassan

Status

Invitation-only

Conditions

Invasive Breast Cancer

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06357338
Soh-Med-24-03-15MS

Details and patient eligibility

About

Retrospective observational study to evaluate c-MYC expression in non invasive and invasive mammry carcinoma

Full description

To correlate different levels of c-MYC expressions with variable clinical and pathological parameters of mammary carcinoma (such as patients' ages, tumor grading, staging, laterality, focality and nodal metastasis, co-existing in-situ components). This study will be carried out on archived formalin-fixed and paraffin embedded tissue blocks that were belonged to 70 women with breast lumps.

Enrollment

70 estimated patients

Sex

Female

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Specimens of Modified Radical Mastectomies from breast carcinoma patients

Exclusion criteria

  • Cases with insufficient clinical data.

    • Tissue blocks of destroyed or insufficient material, unfit for diagnosis.
    • Cases who received pre-operative chemotherapy.

Trial design

70 participants in 2 patient groups

non invasive mammary carcinoma
Description:
35 cases with non invasive breast cancer with low and high nuclear grades and co existing microfoci of invasion
Treatment:
Other: no intervention
invasive mammary carcinoma
Description:
35 cases of invasive breast cancer undergone MRM and classify them according grading, staging and luminal subtypes
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems